These symptoms are not well-characterised. This taskforce aimed to define the clinical characteristics of patients with arthralgia who are considered at risk for RA by experts based on their clinical ...
In this review we describe RA pathogenesis with a focus on knowledge obtained from patients with arthralgia, pre-RA and recently diagnosed RA. Connections are proposed between altered immune cells, ...
Recordati today announces an agreement with Sanofi to acquire the global rights to Enjaymo® (sutimlimab), a biologic which is the only approved targeted product for the treatment of cold agglutinin ...
Yes, there is an increase in AS cases following Covid. There is a high incidence of post-viral arthralgia; the covid virus is well-known for producing inflammatory markers in the body, and we are ...
The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.
GlobalData’s report assesses the drugs in the Collagenase 3 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.